Pay in installments of $12.63 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 22 - Jul 27
For Your Every Summer RSVP, with Code: SUMMER15
Description
No More Tears: The Dark Secrets of Johnson & JohnsonNEW YORK TIMES BESTSELLER An explosive, deeply reported expos of Johnson & Johnson, one of America's oldest and most trusted pharmaceutical companies from an award winning investigative journalist "A damning portrait." Associated Press "A page turning drama that raises life or death questions about the world's largest healthcare conglomerate." Jonathan Eig, Pulitzer Prize winning author of King: A Life One day in 2004, Gardiner Harris, a
NEW YORK TIMES BESTSELLER - An explosive, deeply reported exposé of Johnson & Johnson, one of America's oldest and most trusted pharmaceutical companies--from an award-winning investigative journalist "A damning portrait."--Associated Press "A page-turning drama that raises life-or-death questions about the world's largest healthcare conglomerate."--Jonathan Eig, Pulitzer Prize-winning author of King: A Life One day in 2004, Gardiner Harris, a pharmaceutical reporter for The New York Times, was early for a flight and sat down at an airport bar. He struck up a conversation with the woman on the barstool next to him, who happened to be a drug sales rep for Johnson & Johnson. Her horrific story about unethical sales practices and the devastating impact they'd had on her family fundamentally changed the nature of how Harris would cover the company--and the entire pharmaceutical industry--for the Times. His subsequent investigations and ongoing research since that very first conversation led to this book--a blistering exposé of a trusted American institution and the largest healthcare conglomerate in the world. Harris takes us light-years away from the company's image as the child-friendly "baby company" as he uncovers reams of evidence showing decades of deceitful and dangerous corporate practices that have threatened the lives of millions. He covers multiple disasters: lies and cover-ups regarding the link of Johnson's Baby Powder to cancer, the surprising dangers of Tylenol, a criminal campaign to sell antipsychotics that have cost countless lives, a popular drug used to support cancer patients that actually increases the risk that cancer tumors will grow, and deceptive marketing that accelerated opioid addictions through their product Duragesic (fentanyl) that rival even those of the Sacklers and Purdue Pharma. Filled with shocking and infuriating but utterly necessary revelations, No More Tears is a landmark work of investigative journalism that lays bare the deeply rooted corruption behind the image of babies bathing with a smile.Author: Gardiner Harris
Publisher: Random House
Published: 04/08/2025
Pages: 464
Binding Type: Hardcover
Weight: 1.60lbs
Size: 9.30h x 6.50w x 1.50d
ISBN: 9780593229866
Review Citation(s):
Publishers Weekly 02/24/2025
Library Journal 03/21/2025 pg. 1
Booklist 04/01/2025 pg. 28
About the Author
Gardiner Harris previously served as the public health and pharmaceutical reporter for The New York Times and is now a freelance investigative journalist. He also served as a White House, South Asia, and international diplomacy reporter for the Times. Before that, he was a reporter for The Wall Street Journal, covering the pharmaceutical industry. His investigations there led to what was then the largest fine in the history of the Securities and Exchange Commission. Previously, he was the Appalachian reporter for The Courier-Journal of Louisville, Kentucky. He won the Worth Bingham Prize for investigative journalism and the George Polk Award for environmental reporting after revealing that coal companies deliberately and illegally exposed miners to toxic levels of coal dust. Harris's novel, Hazard, draws on his experience investigating these conditions. He has also been a Pulitzer Prize finalist with a team of others at the Times. He lives in San Diego, California.
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.5 ★★★★★
Based on 9 reviews
Sort
Product Reviews
★★★★★ 5
Nice quality sweater, well made and soft.
Size: Large, Color: Pure Beige
I love this sweater - but I bought it just in time for summer, so it won't get much use until fall! It fits great, it is really soft and the overall quality is quite good. I plan to buy another one in another color as well.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 22, 2026
★★★★★ 4
Nice casual looking sweater
Size: Small, Color: Pure Black
I purchased the black/cream inset sweater in a small. I usually wear a small. I fits loose, but NOT baggy. I like the loose fit. The sweater feels so soft. Nice looking sweater. Very happy with the sweater, but could have ordered a medium for a boxier fit.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 20, 2026
★★★★★ 5
Good quality & trendy color sweater
Size: Large, Color: Pure Apricot
This sweater is very soft, light and very suitable for keeping mild warm at the temperature of 20c or inside an air conditioning room. Particularly, the trendy color for 2026 in brown suede jacket, this sweater is real good matching item! I like it! 😍😍😍
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 27, 2026
★★★★★ 5
very stylish
Size: Medium, Color: Pure Apricot
true to size. very comfortable.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 1, 2026
★★★★★ 5
Great Material
Love the sweater. So soft.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 23, 2026